Thomas Williams McLean (Thomas W McLean)

Years Active: 2018-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra J Borst, Whitney Eng, Morgan Griffin, Kiersten W Ricci, Elissa Engel, Denise M Adams, Jillian Dayneka, Sally J Cohen-Cutler, Steven M Andreoli, Melinda D Wu, Allison P Wheeler, Kenneth M Heym, Shelley E Crary, Taizo A Nakano, Rachael R Schulte, Bhuvana A Setty, Thomas Williams McLean, Kristy S Pahl, Stefanos Intzes, Irina Pateva, Max Teitelbaum, Zili Zong, Yimei Li, Michael Raymond Jeng
Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study. Pediatric blood & cancer (2023)
Jorie E Gatts, Marie C Rush, Jennifer F Check, Diane M Samelak, Thomas Williams McLean
Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age. Pediatric dermatology 39 (3) (2022)
Thomas Williams McLean, Ryan Michael Stewart, Thomas Patrick Curley, Mark Young Dewsnup, Sydney Gillian Thomas, Thomas Bennett Russell, Janet Austin Tooze
Hypoalbuminemia in children with cancer treated with chemotherapy. Pediatric blood & cancer 67 (2) (2019)
L Lee Dupuis, Roy N Tamura, Kara M Kelly, Jeffrey P Krischer, Anne-Marie Langevin, Lu Chen, E Anders Kolb, Nicole J Ullrich, Olle Jane Z Sahler, Eleanor Hendershot, Ann Stratton, Lillian Sung, Thomas Williams McLean
Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy. Pediatric blood & cancer 66 (4) (2018)
Thomas Williams McLean
Surveillance imaging in pediatric melanoma. Pediatric blood & cancer 66 (2) (2018)

Thomas Williams McLean.css-eqlu8i{font-size:small;padding-left:4px;} (Thomas W McLean)